Laham, Yousef, Shimrit Ringelstein-Harlev, Daniel Kurnik, Riva Fineman, Dana Yehudai-Ofir, Lilach Bonstein, Noga Setter-Marco, Eyal Braun, Itai Ghersin, Tsila Zuckerman, and Ofrat Beyar-Katz. 2020. “High-Dose Intravenous Immunoglobulin May Be an Efficient Treatment Option for Patients With Late-Onset High-Grade Immune Effector Cell-Associated Hematotoxicity Refractory to Standard Therapies”. Haematologica, September. Pavia, Italy. https://doi.org/10.3324/haematol.2024.286714.